{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:58:21Z","timestamp":1792036701778,"version":"4.4.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021YQ57\uff0cZR2024MH266"],"award-info":[{"award-number":["ZR2021YQ57\uff0cZR2024MH266"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81803895"],"award-info":[{"award-number":["No.81803895"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07530-y","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T19:35:15Z","timestamp":1764704115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Deciphering USP8\u2019s pivotal role in cancer: mechanisms, clinical insights and contrasts with its function in pituitary adenomas"],"prefix":"10.1186","volume":"24","author":[{"given":"Lifan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8668-0433","authenticated-orcid":false,"given":"Lina","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"4","key":"7530_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26(4):399\u2013422.","journal-title":"Cell Res"},{"issue":"6","key":"7530_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ncb3358","volume":"18","author":"R Yau","year":"2016","unstructured":"Yau R, Rape M. The increasing complexity of the ubiquitin code. Nat Cell Biol. 2016;18(6):579\u201386.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"7530_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Therapy. 2020;5(1):11.","journal-title":"Signal Transduct Target Therapy"},{"issue":"14","key":"7530_CR4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1096\/fasebj.11.14.9409543","volume":"11","author":"KD Wilkinson","year":"1997","unstructured":"Wilkinson KD. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 1997;11(14):1245\u201356.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"9","key":"7530_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5483\/BMBRep.2014.47.9.128","volume":"47","author":"CW Park","year":"2014","unstructured":"Park CW, Ryu KY. Cellular ubiquitin pool dynamics and homeostasis. BMB Rep. 2014;47(9):475\u201382.","journal-title":"BMB Rep"},{"issue":"7","key":"7530_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nri2337","volume":"8","author":"SC Sun","year":"2008","unstructured":"Sun SC. Deubiquitylation and regulation of the immune response. Nat Rev Immunol. 2008;8(7):501\u201311.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"7530_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discovery. 2018;17(1):57\u201378.","journal-title":"Nat Rev Drug Discovery"},{"issue":"5","key":"7530_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","volume":"123","author":"SM Nijman","year":"2005","unstructured":"Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell. 2005;123(5):773\u201386.","journal-title":"Cell"},{"issue":"3","key":"7530_CR9","doi-asserted-by":"publisher","first-page":"101077","DOI":"10.1016\/j.jbc.2021.101077","volume":"297","author":"NA Snyder","year":"2021","unstructured":"Snyder NA, Silva GM. Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response. J Biol Chem. 2021;297(3):101077.","journal-title":"J Biol Chem"},{"issue":"1","key":"7530_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41435-021-00125-9","volume":"22","author":"A Georges","year":"2021","unstructured":"Georges A, Gros P, Fodil N. USP15: a review of its implication in immune and inflammatory processes and tumor progression. Genes Immun. 2021;22(1):12\u201323.","journal-title":"Genes Immun"},{"issue":"1","key":"7530_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2174\/157016308783769469","volume":"5","author":"M Komada","year":"2008","unstructured":"Komada M. Controlling receptor downregulation by ubiquitination and deubiquitination. Curr Drug Discov Technol. 2008;5(1):78\u201384.","journal-title":"Curr Drug Discov Technol"},{"issue":"42","key":"7530_CR12","doi-asserted-by":"publisher","first-page":"30929","DOI":"10.1074\/jbc.M704009200","volume":"282","author":"PE Row","year":"2007","unstructured":"Row PE, Liu H, Hayes S, Welchman R, Charalabous P, Hofmann K, Clague MJ, Sanderson CM, Urb\u00e9 S. The MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradation. J Biol Chem. 2007;282(42):30929\u201337.","journal-title":"J Biol Chem"},{"issue":"12","key":"7530_CR13","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1093\/emboj\/17.12.3241","volume":"17","author":"S Naviglio","year":"1998","unstructured":"Naviglio S, Mattecucci C, Matoskova B, Nagase T, Nomura N, Di Fiore PP. Draetta GF: UBPY: a growth-regulated human ubiquitin isopeptidase. EMBO J. 1998;17(12):3241\u201350.","journal-title":"EMBO J"},{"issue":"6","key":"7530_CR14","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/s12276-023-01010-3","volume":"55","author":"W Zhang","year":"2023","unstructured":"Zhang W, Zheng Z, Wang K, Mao W, Li X, Wang G, Zhang Y, Huang J, Zhang N, Wu P, et al. piRNA-1742 promotes renal cell carcinoma malignancy by regulating USP8 stability through binding to HnRNPU and thereby inhibiting MUC12 ubiquitination. Exp Mol Med. 2023;55(6):1258\u201371.","journal-title":"Exp Mol Med"},{"issue":"33","key":"7530_CR15","first-page":"e2302953","volume":"10","author":"J Tang","year":"2023","unstructured":"Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L, Zhou L, Tao Y. Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT. Advanced science (Weinheim. Baden-Wurttemberg Germany). 2023;10(33):e2302953.","journal-title":"Baden-Wurttemberg Germany)"},{"issue":"3","key":"7530_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jmcb\/mjx036","volume":"10","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Yao X, Pang S, Chen P, Jiang W, Shan Z, Zhang Q. The deubiquitinase UCHL5\/UCH37 positively regulates Hedgehog signaling by deubiquitinating smoothened. J Mol Cell Biol. 2018;10(3):243\u201357.","journal-title":"J Mol Cell Biol"},{"issue":"4","key":"7530_CR17","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41418-019-0419-1","volume":"27","author":"S Shin","year":"2020","unstructured":"Shin S, Kim K, Kim HR, Ylaya K, Do SI, Hewitt SM, Park HS, Roe JS, Chung JY, Song J. Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer. Cell Death Differ. 2020;27(4):1341\u201354.","journal-title":"Cell Death Differ"},{"key":"7530_CR18","doi-asserted-by":"publisher","first-page":"9941","DOI":"10.2147\/OTT.S271496","volume":"13","author":"J Sun","year":"2020","unstructured":"Sun J, Shen D, Zheng Y, Ren H, Liu H, Chen X, Gao Y. USP8 inhibitor suppresses HER-2 positive gastric cancer cell proliferation and metastasis via the PI3K\/AKT signaling pathway. OncoTargets Therapy. 2020;13:9941\u201352.","journal-title":"OncoTargets Therapy"},{"issue":"1","key":"7530_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12935-024-03370-w","volume":"24","author":"G Long","year":"2024","unstructured":"Long G, Wang D, Tang J, Hu K, Zhou L. USP8 promotes the tumorigenesis of intrahepatic cholangiocarcinoma via stabilizing OGT. Cancer Cell Int. 2024;24(1):238.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"7530_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41419-023-05747-7","volume":"14","author":"J Tang","year":"2023","unstructured":"Tang J, Long G, Xiao L, Zhou L. USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through \u03b2-catenin stabilization. Cell Death Dis. 2023;14(6):360.","journal-title":"Cell Death Dis"},{"key":"7530_CR21","doi-asserted-by":"publisher","first-page":"923270","DOI":"10.3389\/fonc.2022.923270","volume":"12","author":"MT Islam","year":"2022","unstructured":"Islam MT, Chen FZ, Chen HC, Wahid A. Knockdown of USP8 inhibits prostate cancer cell growth, proliferation, and metastasis and promotes docetaxel\u2019s activity by suppressing the NF-kB signaling pathway. Front Oncol. 2022;12:923270.","journal-title":"Front Oncol"},{"issue":"2","key":"7530_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12020-015-0682-y","volume":"50","author":"F Jian","year":"2015","unstructured":"Jian F, Cao Y, Bian L, Sun Q. USP8: a novel therapeutic target for cushing\u2019s disease. Endocrine. 2015;50(2):292\u20136.","journal-title":"Endocrine"},{"issue":"8","key":"7530_CR23","doi-asserted-by":"publisher","first-page":"102899","DOI":"10.1016\/j.arcmed.2023.102899","volume":"54","author":"RG Rebollar-Vega","year":"2023","unstructured":"Rebollar-Vega RG, Zuarth-V\u00e1zquez JM, Hern\u00e1ndez-Ram\u00edrez LC. Clinical spectrum of USP8 pathogenic variants in cushing\u2019s disease. Arch Med Res. 2023;54(8):102899.","journal-title":"Arch Med Res"},{"issue":"1","key":"7530_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrm.2016.121","volume":"18","author":"J Sch\u00f6neberg","year":"2017","unstructured":"Sch\u00f6neberg J, Lee IH, Iwasa JH, Hurley JH. Reverse-topology membrane scission by the ESCRT proteins. Nat Rev Mol Cell Biol. 2017;18(1):5\u201317.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7530_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-cellbio-100616-060600","volume":"34","author":"J McCullough","year":"2018","unstructured":"McCullough J, Frost A, Sundquist WI. Structures, Functions, and dynamics of ESCRT-III\/Vps4 membrane remodeling and fission complexes. Annu Rev Cell Dev Biol. 2018;34:85\u2013109.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"49","key":"7530_CR26","doi-asserted-by":"publisher","first-page":"38061","DOI":"10.1074\/jbc.M606704200","volume":"281","author":"GV Avvakumov","year":"2006","unstructured":"Avvakumov GV, Walker JR, Xue S, Finerty PJ Jr., Mackenzie F, Newman EM, Dhe-Paganon S. Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8). J Biol Chem. 2006;281(49):38061\u201370.","journal-title":"J Biol Chem"},{"issue":"17","key":"7530_CR27","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1128\/MCB.24.17.7748-7757.2004","volume":"24","author":"X Wu","year":"2004","unstructured":"Wu X, Yen L, Irwin L, Sweeney C, Carraway KL. 3rd: stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. Mol Cell Biol. 2004;24(17):7748\u201357.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"7530_CR28","doi-asserted-by":"publisher","first-page":"107727","DOI":"10.1016\/j.jbc.2024.107727","volume":"300","author":"C Caba","year":"2024","unstructured":"Caba C, Black M, Liu Y, DaDalt AA, Mallare J, Fan L, Harding RJ, Wang YX, Vacratsis PO, Huang R, et al. Autoinhibition of ubiquitin-specific protease 8: insights into domain interactions and mechanisms of regulation. J Biol Chem. 2024;300(10):107727.","journal-title":"J Biol Chem"},{"issue":"16","key":"7530_CR29","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1016\/j.yexcr.2007.07.028","volume":"313","author":"E Mizuno","year":"2007","unstructured":"Mizuno E, Kitamura N, Komada M. 14-3-3-dependent Inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase. Exp Cell Res. 2007;313(16):3624\u201334.","journal-title":"Exp Cell Res"},{"issue":"7","key":"7530_CR30","doi-asserted-by":"publisher","first-page":"E997","DOI":"10.1210\/jc.2015-1453","volume":"100","author":"LG Perez-Rivas","year":"2015","unstructured":"Perez-Rivas LG, Theodoropoulou M, Ferra\u00f9 F, Nusser C, Kawaguchi K, Stratakis CA, Faucz FR, Wildemberg LE, Assi\u00e9 G, Beschorner R, et al. The gene of the Ubiquitin-Specific protease 8 is frequently mutated in adenomas causing cushing\u2019s disease. J Clin Endocrinol Metab. 2015;100(7):E997\u20131004.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7530_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma ZY, Song ZJ, Chen JH, Wang YF, Li SQ, Zhou LF, Mao Y, Li YM, Hu RG, Zhang ZY, et al. Recurrent gain-of-function USP8 mutations in cushing\u2019s disease. Cell Res. 2015;25(3):306\u201317.","journal-title":"Cell Res"},{"issue":"1","key":"7530_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, et al. Mutations in the deubiquitinase gene USP8 cause cushing\u2019s disease. Nat Genet. 2015;47(1):31\u20138.","journal-title":"Nat Genet"},{"issue":"6","key":"7530_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","volume":"20","author":"MJ Clague","year":"2019","unstructured":"Clague MJ, Urb\u00e9 S, Komander D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol. 2019;20(6):338\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"7530_CR34","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1039\/b907669g","volume":"5","author":"Y Ye","year":"2009","unstructured":"Ye Y, Scheel H, Hofmann K, Komander D. Dissection of USP catalytic domains reveals five common insertion points. Mol Biosyst. 2009;5(12):1797\u2013808.","journal-title":"Mol Biosyst"},{"issue":"1","key":"7530_CR35","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s42003-021-02802-x","volume":"4","author":"K Kakihara","year":"2021","unstructured":"Kakihara K, Asamizu K, Moritsugu K, Kubo M, Kitaguchi T, Endo A, Kidera A, Ikeguchi M, Kato A, Komada M, et al. Molecular basis of ubiquitin-specific protease 8 autoinhibition by the WW-like domain. Commun Biology. 2021;4(1):1272.","journal-title":"Commun Biology"},{"key":"7530_CR36","doi-asserted-by":"crossref","unstructured":"Zubair T, Bandyopadhyay D. Small molecule EGFR inhibitors as anti-cancer agents: discovery, mechanisms of action, and opportunities. Int J Mol Sci. 2023;24(3).","DOI":"10.3390\/ijms24032651"},{"issue":"11","key":"7530_CR37","doi-asserted-by":"publisher","first-page":"14999","DOI":"10.18632\/aging.203061","volume":"13","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Xu J, Hu W, Wang F, Zhou Y, Gong W, Xu W. Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases. Aging. 2021;13(11):14999\u20135012.","journal-title":"Aging"},{"issue":"1","key":"7530_CR38","doi-asserted-by":"publisher","first-page":"e15485","DOI":"10.1111\/1759-7714.15485","volume":"16","author":"W Kong","year":"2025","unstructured":"Kong W, Feng X, Yu Z, Qi X, Zhao Z. USP8-mediated PTK7 promotes PIK3CB-related pathway to accelerate the malignant progression of non-small cell lung cancer. Thorac Cancer. 2025;16(1):e15485.","journal-title":"Thorac Cancer"},{"issue":"43","key":"7530_CR39","doi-asserted-by":"publisher","first-page":"40622","DOI":"10.1021\/acsomega.3c05452","volume":"8","author":"B Ibrahim","year":"2023","unstructured":"Ibrahim B, Akere TH, Chakraborty S, Valsami-Jones E, Ali-Boucetta H. Functionalized gold nanoparticles suppress the proliferation of human lung alveolar adenocarcinoma cells by deubiquitinating enzymes Inhibition. ACS Omega. 2023;8(43):40622\u201338.","journal-title":"ACS Omega"},{"key":"7530_CR40","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.2147\/CMAR.S234586","volume":"12","author":"X Jing","year":"2020","unstructured":"Jing X, Chen Y, Chen Y, Shi G, Lv S, Cheng N, Feng C, Xin Z, Zhang L, Wu J. Down-regulation of USP8 inhibits cholangiocarcinoma cell proliferation and invasion. Cancer Manage Res. 2020;12:2185\u201394.","journal-title":"Cancer Manage Res"},{"key":"7530_CR41","doi-asserted-by":"publisher","first-page":"12415","DOI":"10.2147\/CMAR.S259191","volume":"12","author":"Z Rong","year":"2020","unstructured":"Rong Z, Zhu Z, Cai S, Zhang B. Knockdown of USP8 inhibits the growth of lung cancer cells. Cancer Manage Res. 2020;12:12415\u201322.","journal-title":"Cancer Manage Res"},{"issue":"6","key":"7530_CR42","first-page":"1789","volume":"25","author":"A Klein","year":"2004","unstructured":"Klein A, Reichardt W, Jung V, Zang KD, Meese E, Urbschat S. Overexpression and amplification of STK15 in human gliomas. Int J Oncol. 2004;25(6):1789\u201394.","journal-title":"Int J Oncol"},{"issue":"11","key":"7530_CR43","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1093\/emboj\/17.11.3052","volume":"17","author":"JR Bischoff","year":"1998","unstructured":"Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, et al. A homologue of drosophila Aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1998;17(11):3052\u201365.","journal-title":"EMBO J"},{"issue":"1","key":"7530_CR44","doi-asserted-by":"publisher","first-page":"20220562","DOI":"10.1515\/biol-2022-0562","volume":"18","author":"Y Long","year":"2023","unstructured":"Long Y, Hu Z, Yang D, Wang F, Zhao C, Zhang Y, Zhang Y, Ma H, Lv H. Pharmacological Inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth. Open Life Sci. 2023;18(1):20220562.","journal-title":"Open Life Sci"},{"key":"7530_CR45","doi-asserted-by":"crossref","unstructured":"Faltas CL, LeBron KA, Holz MK. Unconventional estrogen signaling in health and disease. Endocrinology. 2020;161(4).","DOI":"10.1210\/endocr\/bqaa030"},{"key":"7530_CR46","doi-asserted-by":"crossref","unstructured":"Zheng L, Yang Q, Li C, Xu G, Yuan Q, Hou J, Wu G. Ubiquitin-specific peptidase 8 modulates cell proliferation and induces cell cycle arrest and apoptosis in breast cancer by stabilizing estrogen receptor alpha. J Oncol. 2023;2023:8483325.","DOI":"10.1155\/2023\/8483325"},{"issue":"1","key":"7530_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cac2.12386","volume":"43","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li Q, Yang J, Xu P, Xuan Z, Xu J, Xu Z. Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination\/degradation of STAT1 in a GTP binding-dependent modality. Cancer Commun (London England). 2023;43(1):123\u201349.","journal-title":"Cancer Commun (London England)"},{"issue":"12","key":"7530_CR48","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1007\/s12033-023-00978-7","volume":"66","author":"T Ma","year":"2024","unstructured":"Ma T, Ge X, Zhu J, Song C, Wang P, Cai J. Dioscin impedes Proliferation, metastasis and enhances autophagy of gastric cancer cells via regulating the USP8\/TGM2 pathway. Mol Biotechnol. 2024;66(12):3700\u201311.","journal-title":"Mol Biotechnol"},{"key":"7530_CR49","doi-asserted-by":"publisher","first-page":"7973","DOI":"10.2147\/OTT.S264108","volume":"13","author":"J Sun","year":"2020","unstructured":"Sun J, Shen D, Gao Y, Zheng Y, Zhao L, Maa M, Liu H, Chen X. Down-Regulation of USP8 suppresses HER-3 positive gastric cancer cells proliferation. OncoTargets Therapy. 2020;13:7973\u201384.","journal-title":"OncoTargets Therapy"},{"issue":"2","key":"7530_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275\u201392.","journal-title":"Cell"},{"key":"7530_CR51","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.12659\/MSM.909235","volume":"24","author":"M Yan","year":"2018","unstructured":"Yan M, Zhao C, Wei N, Wu X, Cui J, Xing Y. High expression of Ubiquitin-Specific protease 8 (USP8) is associated with poor prognosis in patients with cervical squamous cell carcinoma. Med Sci Monitor: Int Med J Experimental Clin Res. 2018;24:4934\u201343.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"2","key":"7530_CR52","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41418-022-01102-z","volume":"30","author":"H Yang","year":"2023","unstructured":"Yang H, Zhang X, Lao M, Sun K, He L, Xu J, Duan Y, Chen Y, Ying H, Li M, et al. Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer. Cell Death Differ. 2023;30(2):560\u201375.","journal-title":"Cell Death Differ"},{"issue":"19","key":"7530_CR53","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.4161\/cc.7.19.6784","volume":"7","author":"M Qiao","year":"2008","unstructured":"Qiao M, Sheng S, Pardee AB. Metastasis and AKT activation. Cell Cycle (Georgetown Tex). 2008;7(19):2991\u20136.","journal-title":"Cell Cycle (Georgetown Tex)"},{"issue":"3","key":"7530_CR54","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/jcp.21616","volume":"218","author":"S Sheng","year":"2009","unstructured":"Sheng S, Qiao M, Pardee AB. Metastasis and AKT activation. J Cell Physiol. 2009;218(3):451\u20134.","journal-title":"J Cell Physiol"},{"issue":"16","key":"7530_CR55","doi-asserted-by":"publisher","first-page":"e108791","DOI":"10.15252\/embj.2021108791","volume":"41","author":"F Xie","year":"2022","unstructured":"Xie F, Zhou X, Li H, Su P, Liu S, Li R, Zou J, Wei X, Pan C, Zhang Z, et al. USP8 promotes cancer progression and extracellular vesicle-mediated CD8\u2009+\u2009T cell exhaustion by deubiquitinating the TGF-\u03b2 receptor T\u03b2RII. EMBO J. 2022;41(16):e108791.","journal-title":"EMBO J"},{"issue":"15","key":"7530_CR56","doi-asserted-by":"publisher","first-page":"8789","DOI":"10.1111\/jcmm.15515","volume":"24","author":"SL Gao","year":"2020","unstructured":"Gao SL, Yin R, Zhang LF, Wang SM, Chen JS, Wu XY, Yue C, Zuo L, Tang M. The oncogenic role of MUC12 in RCC progression depends on c-Jun\/TGF-\u03b2 signalling. J Cell Mol Med. 2020;24(15):8789\u2013802.","journal-title":"J Cell Mol Med"},{"key":"7530_CR57","doi-asserted-by":"crossref","unstructured":"Huang H. Matrix Metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances. Sensors. 2018;18(10).","DOI":"10.3390\/s18103249"},{"issue":"4","key":"7530_CR58","doi-asserted-by":"publisher","first-page":"E97","DOI":"10.1038\/ncb0402-e97","volume":"4","author":"DJ Webb","year":"2002","unstructured":"Webb DJ, Parsons JT, Horwitz AF. Adhesion assembly, disassembly and turnover in migrating cells -- over and over and over again. Nat Cell Biol. 2002;4(4):E97\u2013100.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"7530_CR59","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1046\/j.1471-4159.2002.01200.x","volume":"83","author":"A Misko","year":"2002","unstructured":"Misko A, Ferguson T, Notterpek L. Matrix metalloproteinase mediated degradation of basement membrane proteins in trembler J neuropathy nerves. J Neurochem. 2002;83(4):885\u201394.","journal-title":"J Neurochem"},{"issue":"3","key":"7530_CR60","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41419-022-04749-1","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Peng D, Liu Y, Zhang Q, Liu B, Deng Y, Ding W, Zhou Z, Liu Q. Usp8 promotes tumor cell migration through activating the JNK pathway. Cell Death Dis. 2022;13(3):286.","journal-title":"Cell Death Dis"},{"issue":"22","key":"7530_CR61","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1038\/sj.emboj.7601401","volume":"25","author":"M Uhlirova","year":"2006","unstructured":"Uhlirova M, Bohmann D. JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in drosophila. EMBO J. 2006;25(22):5294\u2013304.","journal-title":"EMBO J"},{"issue":"2","key":"7530_CR62","doi-asserted-by":"publisher","first-page":"e15489","DOI":"10.1111\/1759-7714.15489","volume":"16","author":"Y Wu","year":"2025","unstructured":"Wu Y, Xian D, Liu Y, Huang D, Liu Q, Yang S. USP8-Dependent family tyrosine kinase promotes the malignant progression of esophageal squamous cell carcinoma by upregulating protein tyrosine kinase 2 expression. Thorac Cancer. 2025;16(2):e15489.","journal-title":"Thorac Cancer"},{"issue":"9","key":"7530_CR63","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrc3792","volume":"14","author":"FJ Sulzmaier","year":"2014","unstructured":"Sulzmaier FJ, Jean C, Schlaepfer DD. FAK in cancer: mechanistic findings and clinical applications. Nat Rev Cancer. 2014;14(9):598\u2013610.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"7530_CR64","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13577-023-00992-6","volume":"37","author":"K Gostomczyk","year":"2024","unstructured":"Gostomczyk K, Marsool MDM, Tayyab H, Pandey A, Borowczak J, Macome F, Chacon J, Dave T, Maniewski M, Szylberg \u0141. Targeting Circulating tumor cells to prevent metastases. Hum Cell. 2024;37(1):101\u201320.","journal-title":"Hum Cell"},{"issue":"9","key":"7530_CR65","first-page":"1752","volume":"8","author":"DG Fuja","year":"2018","unstructured":"Fuja DG, Rainusso NC, Shuck RL, Kurenbekova L, Donehower LA, Yustein JT. Transglutaminase-2 promotes metastatic and stem-like phenotypes in osteosarcoma. Am J Cancer Res. 2018;8(9):1752\u201363.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"7530_CR66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13046-024-02966-4","volume":"43","author":"T Li","year":"2024","unstructured":"Li T, Huang M, Sun N, Hua X, Chen R, Xie Q, Huang S, Du M, Zhao Y, Lin Q, et al. Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upregulation. J Experimental Clin Cancer Research: CR. 2024;43(1):50.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"1","key":"7530_CR67","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, Chen Y, Han B. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Therapy. 2022;7(1):286.","journal-title":"Signal Transduct Target Therapy"},{"issue":"10","key":"7530_CR68","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/ncb3236","volume":"17","author":"HC Chen","year":"2015","unstructured":"Chen HC, Kanai M, Inoue-Yamauchi A, Tu HC, Huang Y, Ren D, Kim H, Takeda S, Reyna DE, Chan PM, et al. An interconnected hierarchical model of cell death regulation by the BCL-2 family. Nat Cell Biol. 2015;17(10):1270\u201381.","journal-title":"Nat Cell Biol"},{"issue":"1\u20132","key":"7530_CR69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","volume":"28","author":"D Kaloni","year":"2023","unstructured":"Kaloni D, Diepstraten ST, Strasser A, Kelly GL. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis: Int J Program Cell Death. 2023;28(1\u20132):20\u201338.","journal-title":"Apoptosis: Int J Program Cell Death"},{"issue":"24","key":"7530_CR70","doi-asserted-by":"publisher","first-page":"37013","DOI":"10.18632\/oncotarget.9455","volume":"7","author":"C Le Clorennec","year":"2016","unstructured":"Le Clorennec C, Lazrek Y, Dubreuil O, Larbouret C, Poul MA, Mondon P, Melino G, P\u00e8legrin A, Chard\u00e8s T. The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1\/2- dependent ITCH\/AIP4 activation. Oncotarget. 2016;7(24):37013\u201329.","journal-title":"Oncotarget"},{"issue":"1","key":"7530_CR71","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12964-019-0413-8","volume":"17","author":"C Le Clorennec","year":"2019","unstructured":"Le Clorennec C, Lazrek Y, Dubreuil O, Sampaio C, Larbouret C, Lanotte R, Poul MA, Barret JM, Prost JF, P\u00e8legrin A, et al. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5\/caspase 8-mediated apoptosis of tumor cells. Cell Communication Signaling: CCS. 2019;17(1):106.","journal-title":"Cell Communication Signaling: CCS"},{"issue":"12","key":"7530_CR72","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1158\/0008-5472.CAN-09-3979","volume":"70","author":"A Panner","year":"2010","unstructured":"Panner A, Crane CA, Weng C, Feletti A, Fang S, Parsa AT, Pieper RO. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res. 2010;70(12):5046\u201353.","journal-title":"Cancer Res"},{"key":"7530_CR73","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.2147\/CMAR.S300195","volume":"13","author":"B Duan","year":"2021","unstructured":"Duan B, Wang C, Liu Z, Yang X. USP8 is a novel therapeutic target in melanoma through regulating receptor tyrosine kinase levels. Cancer Manage Res. 2021;13:4181\u20139.","journal-title":"Cancer Manage Res"},{"issue":"1","key":"7530_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41698-025-00850-8","volume":"9","author":"R Saito","year":"2025","unstructured":"Saito R, Fukushima M, Sasaki M, Okamoto A, Ogiwara H. Targeting USP8 causes synthetic lethality through degradation of FGFR2 in ARID1A-deficient ovarian clear cell carcinoma. NPJ Precision Oncol. 2025;9(1):69.","journal-title":"NPJ Precision Oncol"},{"issue":"2","key":"7530_CR75","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/cr.2008.18","volume":"18","author":"K Al Zaid Siddiquee","year":"2008","unstructured":"Al Zaid Siddiquee K, Turkson J. STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res. 2008;18(2):254\u201367.","journal-title":"Cell Res"},{"key":"7530_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fcell.2017.00031","volume":"5","author":"H Berger","year":"2017","unstructured":"Berger H, Wodarz A, Borchers A. PTK7 faces the Wnt in development and disease. Front Cell Dev Biology. 2017;5:31.","journal-title":"Front Cell Dev Biology"},{"issue":"2","key":"7530_CR77","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"JA Fresno Vara","year":"2004","unstructured":"Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonz\u00e1lez-Bar\u00f3n M. PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193\u2013204.","journal-title":"Cancer Treat Rev"},{"key":"7530_CR78","doi-asserted-by":"crossref","unstructured":"Soonnarong R, Putra ID, Sriratanasak N, Sritularak B, Chanvorachote P. Artonin F induces the ubiquitin-proteasomal degradation of c-Met and decreases Akt-mTOR signaling. Pharmaceuticals (Basel Switzerland). 2022;15(5).","DOI":"10.3390\/ph15050633"},{"issue":"2","key":"7530_CR79","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/onc.2015.79","volume":"35","author":"K He","year":"2016","unstructured":"He K, Zheng X, Li M, Zhang L, Yu J. mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation. Oncogene. 2016;35(2):148\u201357.","journal-title":"Oncogene"},{"issue":"10","key":"7530_CR80","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: regulator of cell death. Cell Death Dis. 2023;14(10):648.","journal-title":"Cell Death Dis"},{"issue":"1","key":"7530_CR81","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41392-022-01300-8","volume":"8","author":"F Shu","year":"2023","unstructured":"Shu F, Xiao H, Li QN, Ren XS, Liu ZG, Hu BW, Wang HS, Wang H, Jiang GM. Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. Signal Transduct Target Therapy. 2023;8(1):32.","journal-title":"Signal Transduct Target Therapy"},{"issue":"3","key":"7530_CR82","doi-asserted-by":"publisher","first-page":"nwaf002","DOI":"10.1093\/nsr\/nwaf002","volume":"12","author":"S Lu","year":"2025","unstructured":"Lu S, Yang Y, Song Z, Cao J, Han Z, Chen L, He Y, Wang J, Teng Y, Zhang Z, et al. Dual functional nanoplatforms potentiate osteosarcoma immunotherapy via microenvironment modulation. Natl Sci Rev. 2025;12(3):nwaf002.","journal-title":"Natl Sci Rev"},{"issue":"1","key":"7530_CR83","doi-asserted-by":"publisher","first-page":"101250","DOI":"10.1016\/j.tranon.2021.101250","volume":"15","author":"MJ Kim","year":"2022","unstructured":"Kim MJ, Choi B, Kim JY, Min Y, Kwon DH, Son J, Lee JS, Lee JS, Chun E, Lee KY. USP8 regulates liver cancer progression via the Inhibition of TRAF6-mediated signal for NF-\u03baB activation and autophagy induction by TLR4. Translational Oncol. 2022;15(1):101250.","journal-title":"Translational Oncol"},{"issue":"9","key":"7530_CR84","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054\u201381.","journal-title":"Autophagy"},{"key":"7530_CR85","doi-asserted-by":"publisher","first-page":"121110","DOI":"10.1016\/j.biomaterials.2021.121110","volume":"277","author":"B Niu","year":"2021","unstructured":"Niu B, Liao K, Zhou Y, Wen T, Quan G, Pan X, Wu C. Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 2021;277:121110.","journal-title":"Biomaterials"},{"issue":"16","key":"7530_CR86","doi-asserted-by":"publisher","first-page":"e2315541121","DOI":"10.1073\/pnas.2315541121","volume":"121","author":"H Li","year":"2024","unstructured":"Li H, Sun Y, Yao Y, Ke S, Zhang N, Xiong W, Shi J, He C, Xiao X, Yu H, et al. USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy. Proc Natl Acad Sci USA. 2024;121(16):e2315541121.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"7530_CR87","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/s41467-022-29401-6","volume":"13","author":"W Xiong","year":"2022","unstructured":"Xiong W, Gao X, Zhang T, Jiang B, Hu MM, Bu X, Gao Y, Zhang LZ, Xiao BL, He C, et al. USP8 Inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy. Nat Commun. 2022;13(1):1700.","journal-title":"Nat Commun"},{"issue":"1","key":"7530_CR88","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s11658-022-00343-7","volume":"27","author":"Y Huang","year":"2022","unstructured":"Huang Y, Xia L, Tan X, Zhang J, Zeng W, Tan B, Yu X, Fang W, Yang Z. Molecular mechanism of LncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR\/PD-L1\/USP8 axis. Cell Mol Biol Lett. 2022;27(1):43.","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"7530_CR89","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1507\/endocrj.EJ19-0239","volume":"67","author":"K Kageyama","year":"2020","unstructured":"Kageyama K, Asari Y, Sugimoto Y, Niioka K, Daimon M. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation. Endocr J. 2020;67(2):177\u201384.","journal-title":"Endocr J"},{"issue":"17","key":"7530_CR90","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.4103\/0366-6999.189047","volume":"129","author":"FF Jian","year":"2016","unstructured":"Jian FF, Li YF, Chen YF, Jiang H, Chen X, Zheng LL, Zhao Y, Wang WQ, Ning G, Bian LG, et al. Inhibition of Ubiquitin-specific peptidase 8 suppresses adrenocorticotropic hormone production and tumorous corticotroph cell growth in AtT20 cells. Chin Med J. 2016;129(17):2102\u20138.","journal-title":"Chin Med J"},{"issue":"1\u20132","key":"7530_CR91","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000500688","volume":"110","author":"A Sesta","year":"2020","unstructured":"Sesta A, Cassarino MF, Terreni M, Ambrogio AG, Libera L, Bardelli D, Lasio G, Losa M, Pecori Giraldi F. Ubiquitin-Specific protease 8 mutant Corticotrope adenomas present unique secretory and molecular features and shed light on the role of ubiquitylation on ACTH processing. Neuroendocrinology. 2020;110(1\u20132):119\u201329.","journal-title":"Neuroendocrinology"},{"issue":"9","key":"7530_CR92","doi-asserted-by":"publisher","first-page":"e3207","DOI":"10.1210\/clinem\/dgaa449","volume":"105","author":"Z Wang","year":"2020","unstructured":"Wang Z, Guo X, Gao L, Deng K, Lian W, Bao X, Feng M, Duan L, Zhu H, Xing B. The immune profile of pituitary adenomas and a novel immune classification for predicting immunotherapy responsiveness. J Clin Endocrinol Metab. 2020;105(9):e3207\u20133223.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"7530_CR93","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s42000-024-00569-4","volume":"23","author":"D Greidinger","year":"2024","unstructured":"Greidinger D, Halperin R, Zemet R, Maixner N, Tirosh A. Somatic USP8 alteration affects the immune landscape of corticotroph pituitary adenomas- a pilot study. Hormones (Athens Greece). 2024;23(4):717\u201325.","journal-title":"Hormones (Athens Greece)"},{"issue":"9","key":"7530_CR94","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni.3230","volume":"16","author":"A Dufner","year":"2015","unstructured":"Dufner A, Kisser A, Niendorf S, Basters A, Reissig S, Sch\u00f6nle A, Aichem A, Kurz T, Schlosser A, Yablonski D, et al. The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cells. Nat Immunol. 2015;16(9):950\u201360.","journal-title":"Nat Immunol"},{"issue":"10","key":"7530_CR95","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/annonc\/mdu242","volume":"25","author":"K Azuma","year":"2014","unstructured":"Azuma K, Ota K, Kawahara A, Hattori S, Iwama E, Harada T, Matsumoto K, Takayama K, Takamori S, Kage M, et al. Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer. Annals Oncology: Official J Eur Soc Med Oncol. 2014;25(10):1935\u201340.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"13","key":"7530_CR96","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1158\/1078-0432.CCR-10-3283","volume":"17","author":"BP Pollack","year":"2011","unstructured":"Pollack BP, Sapkota B, Cartee TV. Epidermal growth factor receptor Inhibition augments the expression of MHC class I and II genes. Clin Cancer Research: Official J Am Association Cancer Res. 2011;17(13):4400\u201313.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"1","key":"7530_CR97","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/bjc.2014.555","volume":"112","author":"A D\u2019Incecco","year":"2015","unstructured":"D\u2019Incecco A, Andreozzi M, Ludovini V, Rossi E, Capodanno A, Landi L, Tibaldi C, Minuti G, Salvini J, Coppi E, et al. PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients. Br J Cancer. 2015;112(1):95\u2013102.","journal-title":"Br J Cancer"},{"issue":"1","key":"7530_CR98","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13045-020-00949-4","volume":"13","author":"J Yuan","year":"2020","unstructured":"Yuan J, Dong X, Yap J, Hu J. The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. J Hematol Oncol. 2020;13(1):113.","journal-title":"J Hematol Oncol"},{"key":"7530_CR99","doi-asserted-by":"crossref","unstructured":"Tian LY, Smit DJ, J\u00fccker M. The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism. Int J Mol Sci. 2023;24(3).","DOI":"10.3390\/ijms24032652"},{"key":"7530_CR100","doi-asserted-by":"crossref","unstructured":"Owen KL, Brockwell NK, Parker BS. JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression. Cancers. 2019;11(12).","DOI":"10.3390\/cancers11122002"},{"key":"7530_CR101","doi-asserted-by":"crossref","unstructured":"Staal J, Beyaert R. Inflammation and NF-\u03baB signaling in prostate cancer: mechanisms and clinical implications. Cells. 2018;7(9).","DOI":"10.3390\/cells7090122"},{"issue":"4","key":"7530_CR102","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MED.0000000000000344","volume":"24","author":"A Ben-Shlomo","year":"2017","unstructured":"Ben-Shlomo A, Cooper O. Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside. Curr Opin Endocrinol Diabetes Obes. 2017;24(4):301\u20135.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"12","key":"7530_CR103","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1172\/JCI60417","volume":"121","author":"H Fukuoka","year":"2011","unstructured":"Fukuoka H, Cooper O, Ben-Shlomo A, Mamelak A, Ren SG, Bruyette D, Melmed S. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas. J Clin Investig. 2011;121(12):4712\u201321.","journal-title":"J Clin Investig"},{"issue":"4","key":"7530_CR104","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1152\/physrev.00024.2017","volume":"98","author":"E Harno","year":"2018","unstructured":"Harno E, Gali Ramamoorthy T, Coll AP, White A. POMC: the physiological power of hormone processing. Physiol Rev. 2018;98(4):2381\u2013430.","journal-title":"Physiol Rev"},{"issue":"1","key":"7530_CR105","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.","journal-title":"Mol Cancer"},{"issue":"5670","key":"7530_CR106","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1126\/science.1096502","volume":"304","author":"Y Samuels","year":"2004","unstructured":"Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, et al. High frequency of mutations of the PIK3CA gene in human cancers. Sci (New York NY). 2004;304(5670):554.","journal-title":"Sci (New York NY)"},{"issue":"1","key":"7530_CR107","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1038\/s41598-023-31759-6","volume":"13","author":"T Vidotto","year":"2023","unstructured":"Vidotto T, Melo CM, Lautert-Dutra W, Chaves LP, Reis RB, Squire JA. Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome. Sci Rep. 2023;13(1):5049.","journal-title":"Sci Rep"},{"issue":"3","key":"7530_CR108","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4161\/cc.9.3.10508","volume":"9","author":"WL Yang","year":"2010","unstructured":"Yang WL, Wu CY, Wu J, Lin HK. Regulation of Akt signaling activation by ubiquitination. Cell Cycle (Georgetown Tex). 2010;9(3):487\u201397.","journal-title":"Cell Cycle (Georgetown Tex)"},{"issue":"41","key":"7530_CR109","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1038\/onc.2008.247","volume":"27","author":"A Carracedo","year":"2008","unstructured":"Carracedo A, Pandolfi PP. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene. 2008;27(41):5527\u201341.","journal-title":"Oncogene"},{"issue":"1","key":"7530_CR110","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s43556-022-00110-2","volume":"3","author":"Q Li","year":"2022","unstructured":"Li Q, Li Z, Luo T, Shi H. Targeting the PI3K\/AKT\/mTOR and RAF\/MEK\/ERK pathways for cancer therapy. Mol Biomed. 2022;3(1):47.","journal-title":"Mol Biomed"},{"issue":"3","key":"7530_CR111","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ejca.2011.11.002","volume":"48","author":"Z Suojun","year":"2012","unstructured":"Suojun Z, Feng W, Dongsheng G, Ting L. Targeting Raf\/MEK\/ERK pathway in pituitary adenomas. Eur J Cancer (Oxford England: 1990). 2012;48(3):389\u201395.","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"issue":"1","key":"7530_CR112","doi-asserted-by":"publisher","first-page":"Rc1","DOI":"10.1007\/BF03347386","volume":"30","author":"I De Martino","year":"2007","unstructured":"De Martino I, Fedele M, Palmieri D, Visone R, Cappabianca P, Wierinckx A, Trouillas J, Fusco A. B-RAF mutations are a rare event in pituitary adenomas. J Endocrinol Investig. 2007;30(1):Rc1\u20133.","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"7530_CR113","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Reviews Clin Oncol. 2018;15(4):234\u201348.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"4","key":"7530_CR114","doi-asserted-by":"publisher","first-page":"R241","DOI":"10.1530\/JME-17-0026","volume":"58","author":"M Sapochnik","year":"2017","unstructured":"Sapochnik M, Fuertes M, Arzt E. Programmed cell senescence: role of IL-6 in the pituitary. J Mol Endocrinol. 2017;58(4):R241\u201353.","journal-title":"J Mol Endocrinol"},{"issue":"12","key":"7530_CR115","doi-asserted-by":"publisher","first-page":"10051","DOI":"10.1002\/jcb.27337","volume":"119","author":"H Qiu","year":"2018","unstructured":"Qiu H, Kong J, Cheng Y, Li G. The expression of ubiquitin-specific peptidase 8 and its prognostic role in patients with breast cancer. J Cell Biochem. 2018;119(12):10051\u20138.","journal-title":"J Cell Biochem"},{"key":"7530_CR116","doi-asserted-by":"crossref","unstructured":"Zhang X, Zeng J, Wang J, Yang Z, Gao S, Liu H, Li G, Zhang X, Gu Y, Pang D. Revealing the potential markers of N(4)-acetylcytidine through acRIP-seq in triple-negative breast cancer. Genes. 2022;13(12).","DOI":"10.3390\/genes13122400"},{"key":"7530_CR117","doi-asserted-by":"publisher","first-page":"215760","DOI":"10.1016\/j.canlet.2022.215760","volume":"542","author":"L Li","year":"2022","unstructured":"Li L, Liu Y, Zhao Y, Feng R, Li Y, Yu X, Liu Z, Wang L. Deubiquitinase USP8 increases ID1 stability and promotes esophageal squamous cell carcinoma tumorigenesis. Cancer Lett. 2022;542:215760.","journal-title":"Cancer Lett"},{"issue":"5","key":"7530_CR118","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s10565-021-09686-x","volume":"39","author":"B Sha","year":"2023","unstructured":"Sha B, Sun Y, Zhao S, Li M, Huang W, Li Z, Shi J, Han X, Li P, Hu T, et al. USP8 inhibitor-induced DNA damage activates cell cycle arrest, apoptosis, and autophagy in esophageal squamous cell carcinoma. Cell Biol Toxicol. 2023;39(5):2011\u201332.","journal-title":"Cell Biol Toxicol"},{"key":"7530_CR119","doi-asserted-by":"publisher","first-page":"115359","DOI":"10.1016\/j.biopha.2023.115359","volume":"166","author":"J Cui","year":"2023","unstructured":"Cui J, Guo Y, Yin T, Gou S, Xiong J, Liang X, Lu C, Peng T. USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2023;166:115359.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"issue":"4","key":"7530_CR120","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/crj.12362","volume":"11","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zhao YF, Zhang MZ, Wu XL. The diagnostic value of tumor markers in Bronchoalveolar lavage fluid for the peripheral pulmonary carcinoma. Clin Respir J. 2017;11(4):481\u20138.","journal-title":"Clin Respir J"},{"issue":"6","key":"7530_CR121","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/pin.12546","volume":"67","author":"Y Kim","year":"2017","unstructured":"Kim Y, Shiba-Ishii A, Nakagawa T, Husni RE, Sakashita S, Takeuchi T, Noguchi M. Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma. Pathol Int. 2017;67(6):292\u2013301.","journal-title":"Pathol Int"},{"issue":"3","key":"7530_CR122","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12020-023-03449-w","volume":"82","author":"HG Vuong","year":"2023","unstructured":"Vuong HG, Dunn IF. The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis. Endocrine. 2023;82(3):527\u201335.","journal-title":"Endocrine"},{"issue":"1","key":"7530_CR123","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A, Letourneur F, Diry S, Diedisheim M, Izac B, et al. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell. 2020;37(1):123\u2013e134125.","journal-title":"Cancer Cell"},{"issue":"3","key":"7530_CR124","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12020-021-02633-0","volume":"71","author":"J D\u00e9nes","year":"2021","unstructured":"D\u00e9nes J, Korbonits M. The clinical aspects of pituitary tumour genetics. Endocrine. 2021;71(3):663\u201374.","journal-title":"Endocrine"},{"issue":"3","key":"7530_CR125","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10014-021-00410-5","volume":"38","author":"C Inomoto","year":"2021","unstructured":"Inomoto C, Tahara S, Oyama K, Kimura M, Matsuno A, Teramoto A, Osamura RY. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms. Brain Tumor Pathol. 2021;38(3):183\u20138.","journal-title":"Brain Tumor Pathol"},{"issue":"1","key":"7530_CR126","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40478-022-01437-1","volume":"10","author":"LG Perez-Rivas","year":"2022","unstructured":"Perez-Rivas LG, Simon J, Albani A, Tang S, Roeber S, Assi\u00e9 G, Deutschbein T, Fassnacht M, Gadelha MR, Hermus AR, et al. TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome. Acta Neuropathol Commun. 2022;10(1):139.","journal-title":"Acta Neuropathol Commun"},{"key":"7530_CR127","doi-asserted-by":"crossref","unstructured":"Faucz FR, Tirosh A, Tatsi C, Berthon A, Hern\u00e1ndez-Ram\u00edrez LC, Settas N, Angelousi A, Correa R, Papadakis GZ, Chittiboina P, et al. Somatic USP8 gene mutations are a common cause of pediatric cushing disease. J Clin Endocrinol Metab. 2017;102(8):2836\u201343.","DOI":"10.1210\/jc.2017-00161"},{"issue":"1","key":"7530_CR128","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/cen.15065","volume":"101","author":"H Miao","year":"2024","unstructured":"Miao H, Wang L, Gong F, Duan L, Wang L, Yao Y, Feng M, Deng K, Wang R, Xiao Y, et al. A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours. Clin Endocrinol. 2024;101(1):32\u201341.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"7530_CR129","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12020-018-1776-0","volume":"63","author":"M Losa","year":"2019","unstructured":"Losa M, Mortini P, Pagnano A, Detomas M, Cassarino MF, Pecori Giraldi F. Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas. Endocrine. 2019;63(2):240\u20136.","journal-title":"Endocrine"},{"issue":"1","key":"7530_CR130","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12902-024-01619-z","volume":"24","author":"N Hashemi-Madani","year":"2024","unstructured":"Hashemi-Madani N, Cheraghi S, Emami Z, Mehrjardi AZ, Kaynama MR, Khamseh ME. Targeted analysis of Ubiquitin-Specific peptidase (USP8) in a population of Iranian people with cushing\u2019s disease and a systematic review of the literature. BMC Endocr Disorders. 2024;24(1):86.","journal-title":"BMC Endocr Disorders"},{"issue":"3","key":"7530_CR131","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1210\/js.2017-00364","volume":"2","author":"C Ballmann","year":"2018","unstructured":"Ballmann C, Thiel A, Korah HE, Reis AC, Saeger W, Stepanow S, K\u00f6hrer K, Reifenberger G, Knobbe-Thomsen CB, Knappe UJ, et al. USP8 mutations in pituitary Cushing Adenomas-Targeted analysis by Next-Generation sequencing. J Endocr Soc. 2018;2(3):266\u201378.","journal-title":"J Endocr Soc"},{"key":"7530_CR132","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fendo.2017.00055","volume":"8","author":"LJ de Ara\u00fajo","year":"2017","unstructured":"de Ara\u00fajo LJ, Lerario AM, de Castro M, Martins CS, Bronstein MD, Machado MC, Trarbach EB. Villares Fragoso MC: transcriptome analysis showed a differential signature between invasive and Non-invasive corticotrophinomas. Front Endocrinol. 2017;8:55.","journal-title":"Front Endocrinol"},{"issue":"2","key":"7530_CR133","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41418-019-0377-7","volume":"27","author":"X Hua","year":"2020","unstructured":"Hua X, Huang M, Deng X, Xu J, Luo Y, Xie Q, Xu J, Tian Z, Li J, Zhu J, et al. The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein. Cell Death Differ. 2020;27(2):632\u201345.","journal-title":"Cell Death Differ"},{"issue":"29","key":"7530_CR134","doi-asserted-by":"publisher","first-page":"19232","DOI":"10.1021\/acsnano.4c05100","volume":"18","author":"X Zhou","year":"2024","unstructured":"Zhou X, Gao F, Gao W, Wang Q, Li X, Li X, Li W, Liu J, Zhou H, Luo A, et al. Bismuth sulfide nanoflowers facilitated miR339 delivery to overcome stemness and radioresistance through Ubiquitin-Specific peptidase 8 in esophageal cancer. ACS Nano. 2024;18(29):19232\u201346.","journal-title":"ACS Nano"},{"issue":"5","key":"7530_CR135","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/mc.22970","volume":"58","author":"J Xu","year":"2019","unstructured":"Xu J, Hua X, Jin H, Zhu J, Li Y, Li J, Huang C. NF\u03baB2 p52 stabilizes rhogdi\u03b2 mRNA by inhibiting AUF1 protein degradation via a miR-145\/Sp1\/USP8-dependent axis. Mol Carcinog. 2019;58(5):777\u201393.","journal-title":"Mol Carcinog"},{"issue":"6","key":"7530_CR136","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1128\/MCB.01245-06","volume":"27","author":"Z Cao","year":"2007","unstructured":"Cao Z, Wu X, Yen L, Sweeney C, Carraway KL. 3rd: Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1. Mol Cell Biol. 2007;27(6):2180\u20138.","journal-title":"Mol Cell Biol"},{"issue":"8","key":"7530_CR137","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41389-021-00348-5","volume":"10","author":"YP Wang","year":"2021","unstructured":"Wang YP, Liu IJ, Chen KC, Wu HC. NOTCH1 signaling promotes protein stability of HER3 through the AKT pathway in squamous cell carcinoma of head and neck. Oncogenesis. 2021;10(8):59.","journal-title":"Oncogenesis"},{"issue":"6","key":"7530_CR138","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.jid.2019.09.024","volume":"140","author":"A McHugh","year":"2020","unstructured":"McHugh A, Fernandes K, Chinner N, Ibrahim AFM, Garg AK, Boag G, Hepburn LA, Proby CM, Leigh IM, Saville MK. The identification of potential therapeutic targets for cutaneous squamous cell carcinoma. J Invest Dermatol. 2020;140(6):1154\u2013e11651155.","journal-title":"J Invest Dermatol"},{"issue":"9","key":"7530_CR139","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.4161\/cc.20174","volume":"11","author":"OA Issaenko","year":"2012","unstructured":"Issaenko OA, Amerik AY. Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes. Cell Cycle (Georgetown Tex). 2012;11(9):1804\u201317.","journal-title":"Cell Cycle (Georgetown Tex)"},{"key":"7530_CR140","doi-asserted-by":"publisher","first-page":"116275","DOI":"10.1016\/j.ejmech.2024.116275","volume":"268","author":"Y Tian","year":"2024","unstructured":"Tian Y, Liu K, Wu D, Wu L, Xu Q, Wei W, Li Z, Du Q, Bian J. The discovery of potent USP2\/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364. Eur J Med Chem. 2024;268:116275.","journal-title":"Eur J Med Chem"},{"issue":"13","key":"7530_CR141","doi-asserted-by":"publisher","first-page":"8914","DOI":"10.1021\/acs.jmedchem.2c00013","volume":"65","author":"Y Tian","year":"2022","unstructured":"Tian Y, Liu K, Liu R, Qiu Z, Xu Y, Wei W, Xu X, Wang J, Ding H, Li Z, et al. Discovery of potent Small-Molecule USP8 inhibitors for the treatment of breast cancer through regulating ER\u03b1 expression. J Med Chem. 2022;65(13):8914\u201332.","journal-title":"J Med Chem"},{"key":"7530_CR142","doi-asserted-by":"publisher","first-page":"103962","DOI":"10.1016\/j.bioorg.2020.103962","volume":"101","author":"J Han","year":"2020","unstructured":"Han J, Tian Y, Yu L, Zhang Q, Xu X, Zhang Y, Wang J, Ma Z, Bian J, Luo C, et al. Discovery of novel USP8 inhibitors via Ubiquitin-Rho-110 fluorometric assay based high throughput screening. Bioorg Chem. 2020;101:103962.","journal-title":"Bioorg Chem"},{"key":"7530_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jare.2022.01.015","volume":"41","author":"Q Sun","year":"2022","unstructured":"Sun Q, Zhang J, Li X, Yang G, Cheng S, Guo D, Zhang Q, Sun F, Zhao F, Yang D, et al. The ubiquitin-specific protease 8 antagonizes melatonin-induced endocytic degradation of MT(1) receptor to promote lung adenocarcinoma growth. J Adv Res. 2022;41:1\u201312.","journal-title":"J Adv Res"},{"key":"7530_CR144","doi-asserted-by":"publisher","first-page":"114900","DOI":"10.1016\/j.bcp.2021.114900","volume":"197","author":"D Colombo","year":"2022","unstructured":"Colombo D, Gatti L, Sj\u00f6strand L, Carenini N, Costantino M, Corna E, Arrighetti N, Zuccolo M, De Cesare M, Linder S, et al. Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells. Biochem Pharmacol. 2022;197:114900.","journal-title":"Biochem Pharmacol"},{"key":"7530_CR145","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1038\/srep04980","volume":"4","author":"YM Oh","year":"2014","unstructured":"Oh YM, Lee SB, Choi J, Suh HY, Shim S, Song YJ, Kim B, Lee JM, Oh SJ, Jeong Y, et al. USP8 modulates ubiquitination of LRIG1 for Met degradation. Sci Rep. 2014;4:4980.","journal-title":"Sci Rep"},{"key":"7530_CR146","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.canlet.2021.11.030","volume":"526","author":"P Chiodelli","year":"2022","unstructured":"Chiodelli P, Coltrini D, Turati M, Cerasuolo M, Maccarinelli F, Rezzola S, Grillo E, Giacomini A, Taranto S, Mussi S, et al. FGFR Blockade by Pemigatinib treats na\u00efve and castration resistant prostate cancer. Cancer Lett. 2022;526:217\u201324.","journal-title":"Cancer Lett"},{"issue":"1","key":"7530_CR147","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41392-022-00959-3","volume":"7","author":"M Wang","year":"2022","unstructured":"Wang M, Zhang Z, Liu J, Song M, Zhang T, Chen Y, Hu H, Yang P, Li B, Song X, et al. Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration. Signal Transduct Target Therapy. 2022;7(1):157.","journal-title":"Signal Transduct Target Therapy"},{"issue":"14","key":"7530_CR148","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1158\/1078-0432.CCR-12-3696","volume":"19","author":"S Byun","year":"2013","unstructured":"Byun S, Lee SY, Lee J, Jeong CH, Farrand L, Lim S, Reddy K, Kim JY, Lee MH, Lee HJ, et al. USP8 is a novel target for overcoming gefitinib resistance in lung cancer. Clin Cancer Research: Official J Am Association Cancer Res. 2013;19(14):3894\u2013904.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"1","key":"7530_CR149","doi-asserted-by":"publisher","first-page":"57","DOI":"10.15430\/JCP.2015.20.1.57","volume":"20","author":"CH Jeong","year":"2015","unstructured":"Jeong CH. Inhibition of Ubiquitin-specific peptidase 8 suppresses growth of Gefitinib-resistant Non-small cell lung cancer cells by inducing apoptosis. J Cancer Prev. 2015;20(1):57\u201363.","journal-title":"J Cancer Prev"},{"key":"7530_CR150","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbrc.2023.10.037","volume":"682","author":"D Jiao","year":"2023","unstructured":"Jiao D, Chen Y, Liu X, Tang X, Chen J, Liu Y, Jiang C, Chen Q. Targeting MET endocytosis or degradation to overcome HGF-induced gefitinib resistance in EGFR-sensitive mutant lung adenocarcinoma. Biochem Biophys Res Commun. 2023;682:371\u201380.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"7530_CR151","first-page":"251","volume":"39","author":"C Xi","year":"2024","unstructured":"Xi C, Gong Z, Ye H, Cao L, Yu J. Inhibition of ubiquitin specific peptidase 8 is effective against 5-fluorouracil resistance in colon cancer via suppressing EGFR and EGFR-mediated signaling pathways. Histol Histopathol. 2024;39(2):251\u201361.","journal-title":"Histol Histopathol"},{"key":"7530_CR152","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"S Vodenkova","year":"2020","unstructured":"Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol Ther. 2020;206:107447.","journal-title":"Pharmacol Ther"},{"issue":"12","key":"7530_CR153","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1038\/emm.2017.255","volume":"49","author":"C Liang","year":"2017","unstructured":"Liang C, Shi S, Meng Q, Liang D, Ji S, Zhang B, Qin Y, Xu J, Ni Q, Yu X. Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going. Exp Mol Med. 2017;49(12):e406.","journal-title":"Exp Mol Med"},{"key":"7530_CR154","doi-asserted-by":"publisher","first-page":"1055067","DOI":"10.3389\/fcell.2022.1055067","volume":"10","author":"C Corno","year":"2022","unstructured":"Corno C, D\u2019Arcy P, Bagnoli M, Paolini B, Costantino M, Carenini N, Corna E, Alberti P, Mezzanzanica D, Colombo D, et al. The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis. Front Cell Dev Biology. 2022;10:1055067.","journal-title":"Front Cell Dev Biology"},{"key":"7530_CR155","doi-asserted-by":"publisher","first-page":"601984","DOI":"10.3389\/fendo.2020.601984","volume":"11","author":"Y Shen","year":"2020","unstructured":"Shen Y, Ji C, Jian X, Zhou J, Zhang Q, Qiao N, Zhang Y, Shou X, Zhou X, Ma Z. Regulation of the EGFR pathway by HSP90 is involved in the pathogenesis of cushing\u2019s disease. Front Endocrinol. 2020;11:601984.","journal-title":"Front Endocrinol"},{"issue":"6","key":"7530_CR156","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1507\/endocrj.EJ18-0491","volume":"66","author":"Y Asari","year":"2019","unstructured":"Asari Y, Kageyama K, Sugiyama A, Kogawa H, Niioka K, Daimon M. Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells. Endocr J. 2019;66(6):515\u201322.","journal-title":"Endocr J"},{"key":"7530_CR157","doi-asserted-by":"crossref","unstructured":"Treppiedi D, Marra G, Di Muro G, Esposito E, Barbieri AM, Catalano R, Mangili F, Bravi F, Locatelli M, Lania AG, et al. P720R USP8 mutation is associated with a better responsiveness to pasireotide in ACTH-secreting PitNETs. Cancers. 2022;14(10).","DOI":"10.3390\/cancers14102455"},{"issue":"8","key":"7530_CR158","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1530\/ERC-22-0088","volume":"29","author":"A Albani","year":"2022","unstructured":"Albani A, Perez-Rivas LG, Tang S, Simon J, Lucia KE, Col\u00f3n-Bolea P, Schopohl J, Roeber S, Buchfelder M, Rotermund R, et al. Improved Pasireotide response in USP8 mutant corticotroph tumours in vitro. Endocrine-related Cancer. 2022;29(8):503\u201311.","journal-title":"Endocrine-related Cancer"},{"key":"7530_CR159","doi-asserted-by":"crossref","unstructured":"Renner U, Ciato D, Stalla GK. Recent advances in understanding corticotroph pituitary tumor initiation and progression. F1000 Research. 2018;7.","DOI":"10.12688\/f1000research.14789.1"},{"issue":"8","key":"7530_CR160","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1530\/ERC-21-0093","volume":"28","author":"D Treppiedi","year":"2021","unstructured":"Treppiedi D, Di Muro G, Marra G, Barbieri AM, Mangili F, Catalano R, Serban A, Ferrante E, Locatelli M, Lania AG, et al. USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs. Endocrine-related Cancer. 2021;28(8):573\u201382.","journal-title":"Endocrine-related Cancer"},{"issue":"D1","key":"7530_CR161","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, Wu J, Tang H, Zheng S, Liu Y, et al. Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53(D1):D1670\u20136.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07530-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07530-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07530-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:02:23Z","timestamp":1767715343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07530-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":161,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7530"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07530-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}